285 related articles for article (PubMed ID: 16427870)
21. Improvement of rat lung structure and function after preservation with celsior.
Fehrenbach A; Wittwer T; Cornelius J; Ochs M; Fehrenbach H; Wahlers T; Richter J
J Surg Res; 1999 Apr; 82(2):285-93. PubMed ID: 10090841
[TBL] [Abstract][Full Text] [Related]
22. Heart preservation with celsior solution improved by the addition of nitroglycerine.
Baxter K; Howden BO; Jablonski P
Transplantation; 2001 May; 71(10):1380-4. PubMed ID: 11391222
[TBL] [Abstract][Full Text] [Related]
23. Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution.
Alves MG; Oliveira PF; Martins FO; Oliveira PJ; Carvalho RA
J Cardiovasc Pharmacol; 2012 Aug; 60(2):227-33. PubMed ID: 22892386
[TBL] [Abstract][Full Text] [Related]
24. Improved recovery of heart transplants with a specific kit of preservation solutions.
Menasché P; Pradier F; Grousset C; Peynet J; Mouas C; Bloch G; Piwnica A
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):353-63. PubMed ID: 8429664
[TBL] [Abstract][Full Text] [Related]
25. Improved preservation of coronary endothelial function with Celsior compared with blood and crystalloid solutions in heart transplantation.
Perrault LP; Nickner C; Desjardins N; Dumont E; Thai P; Carrier M
J Heart Lung Transplant; 2001 May; 20(5):549-58. PubMed ID: 11343982
[TBL] [Abstract][Full Text] [Related]
26. Effects of crystalloid, blood and Celsior solutions on porcine coronary endothelial function after heart transplantation.
Perrault LP; El-Hamamsy I; Dumont E; Malo O; Carrier M
J Heart Lung Transplant; 2005 Jul; 24(7):912-20. PubMed ID: 15982622
[TBL] [Abstract][Full Text] [Related]
27. Gender-dependent metabolic remodeling during heart preservation in cardioplegic celsior and histidine buffer solution.
Alves MG; Oliveira PF; Martins FO; Oliveira PJ; Carvalho RA
J Cardiovasc Pharmacol; 2012 Feb; 59(2):151-7. PubMed ID: 21983744
[TBL] [Abstract][Full Text] [Related]
28. Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from older donors?
Lee S; Huang CS; Kawamura T; Shigemura N; Billiar TR; Nakao A; Toyoda Y
Ann Thorac Surg; 2011 Mar; 91(3):755-63. PubMed ID: 21352993
[TBL] [Abstract][Full Text] [Related]
29. Do preservation solutions protect rat cremaster microcirculation during ischemia and reperfusion?
Bastiaanse J; Slaaf DW; oude Egbrink MG; Boeckx WD; Kon M
J Surg Res; 2005 May; 125(2):182-8. PubMed ID: 15854672
[TBL] [Abstract][Full Text] [Related]
30. Donor heart preservation with a novel hyperpolarizing solution: superior protection compared with University of Wisconsin solution.
Hoenicke EM; Sun X; Strange RG; Damiano RJ
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):746-54. PubMed ID: 11003758
[TBL] [Abstract][Full Text] [Related]
31. Cellular electrophysiologic and mechanical evidence of superior vascular protection in pulmonary microcirculation by Perfadex compared with Celsior.
Wu M; Yang Q; Yim AP; Underwood MJ; He GW
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):492-8. PubMed ID: 19185175
[TBL] [Abstract][Full Text] [Related]
32. Myocardial preservation using Celsior: clinical results in high-risk cardiac transplantation.
Hernández A; Borrego JM; Gomez S; Gutierrez E; Lage E; Hinojosa R; Gonzalez A; Adsuar A; Ordóñez A
Transplant Proc; 2005 Apr; 37(3):1543-5. PubMed ID: 15866667
[TBL] [Abstract][Full Text] [Related]
33. Mechanoenergetics of rat left ventricles in in situ and excised blood-perfused hearts and in unloaded rat left ventricular slices.
Takaki M; Tachibana H; Hata Y; Sakamoto T; Suga H
Heart Vessels; 1997; Suppl 12():100-2. PubMed ID: 9476555
[TBL] [Abstract][Full Text] [Related]
34. Three Preservation Solutions for Cold Storage of Heart Allografts: A Systematic Review and Meta-Analysis.
Li Y; Guo S; Liu G; Yuan Y; Wang W; Zheng Z; Hu S; Ji B
Artif Organs; 2016 May; 40(5):489-96. PubMed ID: 26526678
[TBL] [Abstract][Full Text] [Related]
35. Influence of preservation solution on human islet isolation outcome.
Hubert T; Gmyr V; Arnalsteen L; Jany T; Triponez F; Caiazzo R; Vandewalle B; Vantyghem MC; Kerr-Conte J; Pattou F
Transplantation; 2007 Feb; 83(3):270-6. PubMed ID: 17297400
[TBL] [Abstract][Full Text] [Related]
36. Preoxygenation of different preservation solutions for porcine pancreas preservation.
Hackl F; Stiegler P; Stadlbauer V; Schaffellner S; Iberer F; Matzi V; Maier A; Klemen H; Smolle-Jüttner FM; Tscheliessnigg K
Transplant Proc; 2010 Jun; 42(5):1621-3. PubMed ID: 20620487
[TBL] [Abstract][Full Text] [Related]
37. Pancreas preservation with University of Wisconsin and Celsior solutions.
Boggi U; Coletti L; Vistoli F; Del Chiaro M; Signori S; Croce C; Bartolo TV; Pietrabissa A; Marchetti P; Capocasale E; Dalla Valle R; Mazzoni MP; Mosca F
Transplant Proc; 2004 Apr; 36(3):563-5. PubMed ID: 15110594
[TBL] [Abstract][Full Text] [Related]
38. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants?
Kevelaitis E; Oubénaissa A; Mouas C; Peynet J; Menasché P
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):155-62. PubMed ID: 11135172
[TBL] [Abstract][Full Text] [Related]
39. Elective cardiac surgery using Celsior or St. Thomas No. 2 solution: a prospective, single-center, randomized pilot study.
Pereda D; Castella M; Pomar JL; Cartaña R; Josa M; Barriuso C; Roman J; Mulet J
Eur J Cardiothorac Surg; 2007 Sep; 32(3):501-6. PubMed ID: 17604178
[TBL] [Abstract][Full Text] [Related]
40. May preservation solution affect the incidence of graft vasculopathy in transplanted heart?
Garlicki M
Ann Transplant; 2003; 8(1):19-24. PubMed ID: 12848379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
